Global Patient Recruitment for Clinical Trials Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Global Patient Recruitment for Clinical Trials Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Patient recruitment for clinical trials refers to the process of identifying, screening, and enrolling eligible individuals (patients or participants) into a research study or clinical trial. Clinical trials are conducted to evaluate the safety and effectiveness of new drugs, treatments, medical devices, or interventions, and patient recruitment is a critical step in the trial's success. The goal of patient recruitment is to find and enroll a sufficient number of qualified participants who meet the specific criteria outlined in the trial's protocol.

Market Overview:

The latest research study on the global Patient Recruitment for Clinical Trials market finds that the global Patient Recruitment for Clinical Trials market reached a value of USD 1749.06 million in 2023. It’s expected that the market will achieve USD 2845.54 million by 2029, exhibiting a CAGR of 8.45% during the forecast period.

Drivers

1.There are many activities in the field of clinical research worldwide: Benefiting from innovative drugs and other policies, the number of clinical trial projects is expected to maintain an upward trend, and at the same time, it is expected to increase the business volume of recruiting companies.
2.Increasing Disease Prevalence: The escalation of disease prevalence, characterized by the growing incidence of chronic and complex health conditions, constitutes a compelling driver for the expansion of clinical trials.

Limitations

1.The difficulty of recruitment has increased.
2.Limited patient awareness about clinical trials remains a significant hurdle in the recruitment process.

Opportunities

1.Increasing Industry Investment: The escalating investment by pharmaceutical companies and biotech firms in drug development is a significant Opportunity of patient recruitment for clinical trials.
2.Globalization of Clinical Research: The globalization of clinical research is a transformative trend in the field of patient recruitment for clinical trials.

Region Overview:

China had the highest growth rate of all regions in 2022.

In 2022, the share of the Patient Recruitment for Clinical Trials market in United States stood at 45.23%.

Company Overview:

IQVIA is one of the major players operating in the Patient Recruitment for Clinical Trials market, holding a share of 15.74% in 2023.

IQVIA, PPD, MMG, WCG Clinical and SubjectWell are the five key players in the global Patient Recruitment for Clinical Trials market. These companies have shown consistent growth in revenue, larger volumes of sales and a prominent presence in terms of share in the global Patient Recruitment for Clinical Trials market in the past 5 years.

Segmentation Overview:

The Phase I segment by type showed a value growth of 11.61% in 2022.

Among different product types, Phase III segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Oncology segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Patient Recruitment for Clinical Trials market covered in Chapter 3:

BBK Worldwide
PatientEvolution
Clinical Connection
IQVIA
AutoCruitment
Shanghai Jsure Health Technology
Antidote
Clinical Site Services (CCSi)
PPD
Praxis
Veristat
Clara Health
Clariness
Elligo Health Research
WCG Clinical
MMG
Worldwide Clinical Trials
StudyKIK
SubjectWell
Biorasi

In Chapter 4 and Chapter 14.2, on the basis of types, the Patient Recruitment for Clinical Trials market from 2019 to 2030 is primarily split into:

Phase I
Phase II
Phase III
Phase IV

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Patient Recruitment for Clinical Trials market from 2019 to 2030 covers:

Respiratory Diseases
Pain and Anesthesia
Oncology
Central Nervous System
Cardiovascular

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2019-2030) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)